Real-World Evidence Leader in Inflammatory Bowel Disease, Target RWE, Announces Expanded Footprint with TARGET-GASTRO Registry of 30,000+ Patients At Digestive Disease Week

New Data from IBD Subgroup Analysis Demonstrates Improved Outcomes for Crohn’s Disease Patients DURHAM, N.C., May 17, 2024 /PRNewswire/ — Real-world evidence leader, Target RWE, Real-world evidence leader Target RWE today announced a major expansion of its TARGET-GASTRO longitudinal…